Diagnosis and therapy of ascites;Diagnostik und therapie des aszites

Deutsches Arzteblatt

Volumn 103, Issue 28-29, 2006, Pages

  Wiest, Reiner ^a   Schölmerich, Jürgen ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Ascites; Liver cirrhosis; Peritonitis; Portal hypertension

Indexed keywords

ALBUMIN; ALDOSTERONE ANTAGONIST; AMILORIDE; ANTIBIOTIC AGENT; FUROSEMIDE; LOOP DIURETIC AGENT; SPIRONOLACTONE; TORASEMIDE; VASOPRESSIN RECEPTOR ANTAGONIST;

ARTICLE; ASCITES; CLINICAL EXAMINATION; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DIURESIS; DOSE RESPONSE; HUMAN; LIVER TRANSPLANTATION; PARACENTESIS; RARE DISEASE; SODIUM RESTRICTION; STENT;

EID: 33747303791     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. D'Amico G, Morabito A, Pagliaro L, Marubini E: Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 1986; 31: 468-75.
2. Henriksen JH, Ring-Larsen H: Ascites formation in liver cirrhosis: the how and the why. Dig Dis 1990; 8: 152-62.
3. Arroyo V, Fernandez-Esparrach G, Gines P, Diagnostic approach to the cirrhotic patient with ascites: J Hepatol 1996; 25 (Suppl. 1): 35-40.
4. Moore KP, Wong F, Gines P et al.: The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 2003; 38: 258-66.
5. Cardenas A, Chopra S: Chylous ascites. Am J Gastroenterol 2002; 97: 1896-900.
6. Runyon BA, Montano AA, Akriviadis EA, Antillon MR, Irving MA, McHutchison JG: The serum-ascites albumin gradient is superior to the exudate- transudate concept in the differential diagnosis of ascites. Ann Intern Med 1992; 117: 215-20.
7. Rimola A, Garcia-Tsao G, Navasa M, Piddock LJ, Planas R, Bernard B, Inadomi JM, International Ascites Club: Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol 2000; 32: 142-53.
8. Castellote J, Lopez C, Gornals J et al.: Rapid diagnosis of spontaneous bacterial peritonitis by use of reagent strips. Hepatology 2003; 37: 893-6.
9. Arroyo V, Gines P, Gerbes AL, et al.: Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996; 23: 164-76.
10. Gerbes AL, Bertheau-Reitha U, Falkner C, Jungst D, Paumgartner G: Advantages of the new loop diuretic torasemide over furosemide in patients with cirrhosis and ascites. A randomized, double blind cross-over trial. J Hepatol 1993; 17: 353-8.
11. Gines P, Guevara M, De Las HD, Arroyo V: Review article: albumin for circulatory support in patients with cirrhosis. Aliment Pharmacol Ther 2002; 5 (Suppl 5): 24-31.
12. Boyer TD: Transjugular intrahepatic portosystemic shunt: current status. Gastroenterology 2003; 124: 1700-10.
13. Saab S, Nieto J, Runyon BA: TIPS versus paracentesis for cirrhotic patients with refractory ascites. Cochrane. Database. Syst. Rev 3(CD 004889). 2004.
14. Gines P, Berl T, Bernardi M, Bichet D, Hamon G, Jimenez W, Martin PY, Schrier RW: Hyponatremia in cirrhosis: from pathogenesis to treatment. Hepatology 1998; 28: 851-60.
15. Arroyo V: Clinical need for antidiuretic hormone antagonists in cirrhosis. Hepatology 2003; 37: 13-5.
16. Gerbes AL, Gulberg V, Gines P et al.: Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial. Gastroenterology. 2003; 124: 933-9.
17. Wiest R, Lock G: Das hepatorenale Syndrom: Pathophysiologie und Therapie. Notfall- und Intensivmedizin 2003; 40: 13-33.
18. Sort P, Navasa M, Arroyo V et al.: Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 341: 403-9.